Transparency in Reporting Rare Disease Trial Outcomes: Ethical and Regulatory Imperatives
Transparency in Reporting Rare Disease Trial Outcomes: Ethical and Regulatory Imperatives Ensuring Transparency in Rare Disease Clinical Trial Reporting Why Transparency Matters in Rare Disease Trials In rare disease research, every datapoint matters. Due to the small patient populations, heterogeneous outcomes, and complex endpoints, publishing accurate and timely trial results becomes not just a regulatory…